📝 Editor's Note: A Tidal Wave Is Coming

Trying to type, my constant neuro buddies Spike and Buzz are keeping it down to a dull roar but my mind’s working overtime. Putting together this weeks newsletter I found news that left me stunned. Raising billions of dollars in years ok, maybe months but really WEEKS? That’s a lot to process so jump in the saddle and read on.

Healthcare AI just raised $2 billion in funding. Not in 2025. In three weeks of December.

Let that sink in. That’s a lot of pickup trucks!

This is exciting. This could mean faster diagnoses, better documentation, smarter clinical trial matching, less burnout for the clinicians we depend on. The technology is real and the potential enormous.

But remember having a rare neurological condition makes us, well, sorry friends, but we are small potatoes. So, I have a question that I think we all need to be asking together: How do we make sure this wave helps us too?

Just a genuine question about how we get this right—for everyone?

📋 QUICK READ: What's Inside

$2 billion in 3 weeks — The AI healthcare funding surge
What it's building — Scribes, documentation, trial matching, diagnostics
The opportunity ahead — Expanding access as the technology matures
What you can do — Questions worth asking
Glossary — Terms you'll hear all year

Read time: 5 minutes

💰 THE NUMBERS: DECEMBER 2025

Healthcare AI funding in just the last three weeks:

Company

Amount

What They Do

Abridge

$300M

AI clinical documentation

Ambience Healthcare

$243M

AI clinical scribes

Commure

$200M

Ambient AI platform

Angle Health

$134M

AI-powered benefits

Paradigm Health

$78M

Clinical research AI

Artera

$65M

AI patient communication

JP Morgan reports that 75% of all healthcare investment dollars in 2025 went to AI-focused deals. Mayo Clinic committed $1 billion to AI across 200+ projects. The FDA qualified its first AI tool for drug development on December 9th—for MASH clinical trials.

This isn't just diagnostic support anymore. AI is becoming part of the healthcare infrastructure.

📚 LEARN MORE:

🌟 WHAT THIS COULD MEAN FOR RARE NEURO

For patients living with CIDP, myasthenia gravis, autoimmune encephalitis, or other rare conditions, AI innovation opens real doors:

Faster pattern recognition — AI that spots rare disease signals in data that humans might miss

Reduced clinician burnout — When doctors spend less time on documentation, they have more time for complex cases like ours

Smarter trial matching — AI that connects patients to clinical trials they'd never find on their own

Better remote monitoring — Catching flares early, reducing ER visits

These aren't distant possibilities. They're being built right now.

🤝 THE OPPORTUNITY: EXPANDING ACCESS TOGETHER

Here's what I keep thinking about: Innovation often reaches major academic centers first. That makes sense—they have the infrastructure, the IT teams, the budgets.

But the real win is when these tools reach everyone: the community clinic in East Houston, the rural hospital in West Texas, the small neurology practice serving patients who drive 150 miles for an appointment.

That's the next chapter of this story. And it's one we can all help write.

What healthcare systems can consider:

  • Piloting AI tools in underserved settings, not just flagship hospitals

  • Partnering with rural health networks on implementation

  • Tracking equity metrics alongside efficiency metrics

What patients and advocates can do:

  • Ask your care team: "Are you exploring any AI tools that might help patients like me?"

  • Share your experience with patient advisory boards—your voice shapes what gets prioritized

  • Celebrate wins AND keep asking how to expand them

What AI companies are already starting to do:

  • Designing for lower-bandwidth environments

  • Creating pricing models for smaller practices

  • Building with community health centers as partners, not afterthoughts

The best innovations eventually become accessible to everyone. Let's help that happen faster.

📖 GLOSSARY: TERMS YOU'LL HEAR ALL YEAR

Ambient AI: Technology that listens to clinical conversations and automatically generates documentation—like an AI scribe in the room.

MASH (Metabolic Dysfunction-Associated Steatohepatitis): A form of liver disease. Mentioned because the FDA just qualified AI for these clinical trials—a milestone for AI in drug development.

Agentic AI: AI systems that can take autonomous actions and make decisions with minimal human intervention.

Health Equity: Ensuring all patients and communities can benefit from healthcare innovation, regardless of location or resources.

FQHC (Federally Qualified Health Center): Community health centers that receive federal funding to serve underserved areas.

💬 CAREGIVER CORNER

"I read about all these AI breakthroughs and I think—I hope this reaches us someday. We're three hours from the nearest neurologist. Anything that helps our local clinic help us better? I'm cheering for it."
— Maria, South Texas caregiver

🔗 YOUR TOOLKIT

Stay Informed:

Rural & Community Health:

Patient Advocacy:

📰 FROM TEXAS NEURORARE NETWORK

Texas NeuroRare (Tuesdays): CAR-T updates, clinical trial access, insurance navigation—patient advocacy with a Texas heart. [Subscribe]

RarelySerious (Fridays): "My AI Scribe Spelled My Diagnosis Wrong. At Least It's Consistent." Healthcare humor for people who need to laugh. [Subscribe]

📧 Let's Talk

What's your experience with AI in your clinic or care? Seeing promising changes? Hoping for more access? We'd love to hear.

Email [email protected] We do read everything.

THE BOTTOM LINE: $2 billion is flowing into healthcare AI. The technology is real and promising. The opportunity now is making sure it reaches everyone—and that's a challenge we can work on together.

⚠️ DISCLAIMER

Educational information only. Not medical advice.

Always consult your healthcare provider before making treatment decisions or using/stopping AI tools in your care.

Information sourced from peer-reviewed research, clinical literature, NORD, GBS/CIDP Foundation (December 2025).

Privacy: We collect only email and voluntary feedback. No selling, sharing, or AI training without consent.

Spotted an error? Tell us—feedback keeps us honest.

Copyright © 2025 Texas NeuroRare Network

THANK Y’ALL FOR READING!

Keep Reading

No posts found